{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T05:21:56Z","timestamp":1777785716241,"version":"3.51.4"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,3,18]]},"abstract":"<jats:p>\n            OPS-2071 is a novel quinolone antibacterial agent characterized by low oral absorption that reduces the risk of adverse events typical of fluoroquinolone class antibiotics. The\n            <jats:italic>in vitro<\/jats:italic>\n            and\n            <jats:italic>in vivo<\/jats:italic>\n            antibacterial activities of OPS-2071 against\n            <jats:named-content content-type=\"genus-species\">Clostridioides difficile<\/jats:named-content>\n            were evaluated in comparison to vancomycin and fidaxomicin.\n          <\/jats:p>","DOI":"10.1128\/aac.01170-20","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T13:21:47Z","timestamp":1611753707000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["<i>In Vitro<\/i>\n            and\n            <i>In Vivo<\/i>\n            Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile"],"prefix":"10.1128","volume":"65","author":[{"given":"Daisuke","family":"Oka","sequence":"first","affiliation":[{"name":"Department of Medical Innovations, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomitsu","family":"Yamaya","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kuno","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Investigative Toxicology, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Shiragiku","sequence":"additional","affiliation":[{"name":"Department of Drug Safety Research, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"Otsuka Shanghai Research Institute, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Xue","sequence":"additional","affiliation":[{"name":"Otsuka Shanghai Research Institute, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abudusaimi","family":"Mamuti","sequence":"additional","affiliation":[{"name":"Otsuka Shanghai Research Institute, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangguo","family":"Ye","sequence":"additional","affiliation":[{"name":"Otsuka Shanghai Research Institute, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangqin","family":"Sun","sequence":"additional","affiliation":[{"name":"Otsuka Shanghai Research Institute, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinue","family":"Ohguro","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medical Innovations, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitaka","family":"Uematsu","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-6360","authenticated-orcid":true,"given":"Katsuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medical Innovations, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Fei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Otsuka Shanghai Research Institute, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506004"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00165-06"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408913"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4609"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902816R"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61266-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit127"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3977"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2019.102074"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.027"},{"key":"e_1_3_3_12_2","first-page":"263","article-title":"Clostridium difficile infection in patients with inflammatory bowel disease","volume":"24","author":"Saidel-Odes L","year":"2011","unstructured":"Saidel-Odes L, Borer A, Odes S. 2011. Clostridium difficile infection in patients with inflammatory bowel disease. Ann Gastroenterol 24:263\u2013270.","journal-title":"Ann Gastroenterol"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000968"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i27.4986"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.12.028"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy149"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i8.777"},{"key":"e_1_3_3_18_2","volume-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement, CLSI document M100-S22.","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement, CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/496986"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051590"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051639"},{"key":"e_1_3_3_22_2","first-page":"9","article-title":"Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244","volume":"126","author":"DeAlmeida MN","year":"2013","unstructured":"DeAlmeida MN, Heffernan H, Dervan A, Bakker S, Freeman JT, Bhally H, Taylor SL, Riley TV, Roberts SA. 2013. Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244. N Z Med J 126:9\u201314.","journal-title":"N Z Med J"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu203"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/649213"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.46.11.3418-3421.2002"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223326"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02157-17"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01904-18"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.35.6.1108"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv005"},{"key":"e_1_3_3_31_2","volume-title":"Antibiotic resistance threats in the United States, 2013.","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S127099"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz078"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg212"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1039\/c9md00120d"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00015-12"},{"key":"e_1_3_3_37_2","volume-title":"StatPearls.","author":"Levitus M","year":"2020","unstructured":"Levitus M, Rewane A, Perera TB. 2020. Vancomycin-resistant enterococci (VRE). StatPearls. StatPearls Publishing LLC, Treasure Island, FL."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis337"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2014.88"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2017.02.018"},{"key":"e_1_3_3_41_2","unstructured":"Science Council of Japan. 2006. Guidelines for proper conduct of animal experiments. Science Council of Japan. http:\/\/www.scj.go.jp\/en\/animal\/."},{"key":"e_1_3_3_42_2","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 8th ed. CLSI document M11-A8. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"8"},{"key":"e_1_3_3_43_2","volume-title":"Performance standards for antimicrobial susceptibility testing; 22nd informational supplement.","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-246-5_2"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.suppl_a.37"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(85)90046-3"}],"updated-by":[{"DOI":"10.1128\/aac.02338-21","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000}}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01170-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01170-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:40:35Z","timestamp":1645486835000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01170-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,18]]}},"alternative-id":["10.1128\/AAC.01170-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01170-20","relation":{"correction":[{"id-type":"doi","id":"10.1128\/aac.02338-21","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"2020-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01170-20"}}